There is no statistically significant correlation between CIPN and the molecular subtypes of breast cancer, this is different from the observations made in a study by Candeliero et al [32] where Her 2/Neu positivity is a statistically significant predictor of CIPN. The gene discussed is ERBB2; the disease is breast carcinoma.